Many pathology groups have a common misunderstanding when expanding into molecular testing: underestimating the operational burden of later ...
This fully-automated, quality-driven utilization management (UM) solution empowers health plans to seamlessly transition specialist groups toward value based care by directly rewarding optimal ...
CMS has spent the past three years systematically expanding colorectal cancer screening coverage — adding new modalities, eliminating patient cost-sharing and lowering the eligible age. For ...
The US Food and Drug Administration (FDA) revised its compliance program guide (CPG) for preapproval inspections (PAIs) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results